Evidence map›Paper›PMID 31127461›Full record

ReviewClinical rheumatology2020

A global perspective on the challenges and opportunities in learning about rheumatic and musculoskeletal diseases in undergraduate medical education : White paper by the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD).

Mustafa Al Maini, Yousef Al Weshahi, Helen E Foster, Mellick J Chehade, Sherine E Gabriel, Jamal Al Saleh, Humaid Al Wahshi, Johannes W J Bijlsma, Maurizio Cutolo, Sharad Lakhanpal and 3 more

Abstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Exploring the awareness, attitude, and inclination of healthcare students towards interprofessional education: A cross-sectional study in Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mustafa Al MainiMafraq Hospital, Abu Dhabi, United Arab Emirates. mmaini@wfrmd.org.
Yousef Al WeshahiOman Medical Specialty Board, Muscat, Sultanate of Oman.
Helen E FosterNewcastle University Medicine Malaysia, Gelang Patah, Johor, Malaysia.
Mellick J ChehadeDiscipline of Orthopaedics and Trauma, Royal Adelaide Hospital and University of Adelaide, Adelaide, Australia.
Sherine E GabrielRobert Wood Johnson Medical School, Rutgers University, Camden, NJ, USA.
Jamal Al SalehDubai Hospital, Dubai, United Arab Emirates.
Humaid Al WahshiRoyal Hospital, Muscat, Sultanate of Oman.
Johannes W J BijlsmaUtrecht University, Utrecht, The Netherlands.
Maurizio CutoloResearch Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Sharad LakhanpalUT Southwestern Medical Center, Dallas, TX, USA.
Manda VenkatramanaGulf Medical University, Ajman, United Arab Emirates.
Carlos PinedaInstituto Nacional de Rehabilitación, Mexico City, Mexico.
Anthony D WoolfRoyal Cornwall Hospital and University of Exeter Medical School, Truro, UK.

Funding

World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD) Not applicable
6 · The paper itself

Abstract

Rheumatic and musculoskeletal diseases (RMDs) encompass a spectrum of degenerative, inflammatory conditions predominantly affecting the joints. They are a leading cause of disability worldwide and an enormous socioeconomic burden. However, worldwide deficiencies in adult and paediatric RMD knowledge among medical school graduates and primary care physicians (PCPs) persist. In October 2017, the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD), an international think tank of RMD and related experts, met to discuss key challenges and opportunities in undergraduate RMD education. Topics included needs analysis, curriculum content, interprofessional education, teaching and learning methods, implementation, assessment and course evaluation and professional formation/career development, which formed a framework for this white paper. We highlight a need for all medical graduates to attain a basic level of RMD knowledge and competency to enable them to confidently diagnose, treat/manage or refer patients. The importance of attracting more medical students to a career in rheumatology, and the indisputable value of integrated, multidisciplinary and multiprofessional care are also discussed. We conclude that RMD teaching for the future will need to address what is being taught, but also where, why and to whom, to ensure that healthcare providers deliver the best patient care possible in their local setting.

Indexed as

Career ChoiceCurriculumDelivery of Health CareEducation, Medical, UndergraduateHumansMusculoskeletal DiseasesRheumatic DiseasesRheumatologyEducationLearningMedical studentPaediatricsRheumatic and musculoskeletal diseasesRheumatologyUndergraduate

Identifiers

PMID31127461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.